Search for the latest updates on diabetes
News
Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline ... PR Newswire via Yahoo Canada Finance - 36 minutes
BOSTON, Oct. 1, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced successful top-line results from two of its four phase 3 ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment